Atomoxetin Hydrochloride marketed by Glenmark Pharmaceuticals Inc., USA under NDC Code 68462-269-30
NDC Code(s) : 68462-265-30, 68462-265-23, 68462-266-30, 68462-266-23, 68462-267-30, 68462-267-23, 68462-268-30, 68462-268-23, 68462-269-30, 68462-269-23, 68462-270-30, 68462-270-23, 68462-271-30, 68462-271-51
Packager : Glenmark Pharmaceuticals Inc., USA
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
atomoxetineatomoxetine CAPSULE |
|
|
|
|
|
|
atomoxetineatomoxetine CAPSULE |
|
|
|
|
|
|
atomoxetineatomoxetine CAPSULE |
|
|
|
|
|
|
atomoxetineatomoxetine CAPSULE |
|
|
|
|
|
|
atomoxetineatomoxetine CAPSULE |
|
|
|
|
|
|
atomoxetineatomoxetine CAPSULE |
|
|
|
|
|
|
atomoxetineatomoxetine CAPSULE |
|
|
|
|
|
|
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.